Invention Grant
US09481690B2 Polymorphs of 2-(4-(2-(1-(isopropyl-3-methyl-1H-1,2,4,triazol-5-yl)-5,6-dihydrobenzo[f] imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide, methods of production, and pharmaceutical uses thereof 有权
2-(4-(2-(1-(异丙基-3-甲基-1H-1,2,4-三唑-5-基)-5,6-二氢苯并[f]咪唑并[1,2-d ] [1,4]氧氮杂-9-基)-1H-吡唑-1-基)-2-甲基丙酰胺,其制备方法及其药学用途

  • Patent Title: Polymorphs of 2-(4-(2-(1-(isopropyl-3-methyl-1H-1,2,4,triazol-5-yl)-5,6-dihydrobenzo[f] imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide, methods of production, and pharmaceutical uses thereof
  • Patent Title (中): 2-(4-(2-(1-(异丙基-3-甲基-1H-1,2,4-三唑-5-基)-5,6-二氢苯并[f]咪唑并[1,2-d ] [1,4]氧氮杂-9-基)-1H-吡唑-1-基)-2-甲基丙酰胺,其制备方法及其药学用途
  • Application No.: US14991658
    Application Date: 2016-01-08
  • Publication No.: US09481690B2
    Publication Date: 2016-11-01
  • Inventor: Jeffrey StultsTravis RemarchukFrederic St-Jean
  • Applicant: Genentech, Inc.
  • Applicant Address: unknown South San Francisco
  • Assignee: Genentech, Inc.
  • Current Assignee: Genentech, Inc.
  • Current Assignee Address: unknown South San Francisco
  • Main IPC: C07D498/04
  • IPC: C07D498/04 A61K31/553 C07D498/06 A61K45/06
Polymorphs of 2-(4-(2-(1-(isopropyl-3-methyl-1H-1,2,4,triazol-5-yl)-5,6-dihydrobenzo[f] imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide, methods of production, and pharmaceutical uses thereof
Abstract:
The present invention relates to crystalline polymorphs of (2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide (GDC-0032, taselisib), methods of use, and processes of preparing thereof.
Information query
Patent Agency Ranking
0/0